|
🐜
|
Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
16 auth.
F. Perros,
D. Montani,
P. Dorfmüller,
I. Durand‐Gasselin,
C. Tcherakian,
J. Le Pavec,
M. Mazmanian,
E. Fadel,
S. Mussot,
O. Mercier,
...
P. Hervé,
D. Émilie,
S. Eddahibi,
G. Simonneau,
R. Souza,
M. Humbert
|
8 |
2008 |
8
🐜
|
|
🐜
|
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
8 auth.
X. Jais,
D. Launay,
A. Yaici,
J. Le Pavec,
C. Tcherakian,
O. Sitbon,
...
G. Simonneau,
M. Humbert
|
8 |
2008 |
8
🐜
|
|
🐜
|
Pulmonary Veno-Occlusive Disease: Clinical, Functional, Radiologic, and Hemodynamic Characteristics and Outcome of 24 Cases Confirmed by Histology
16 auth.
D. Montani,
L. Achouh,
P. Dorfmüller,
J. Le Pavec,
B. Sztrymf,
C. Tcherakian,
A. Rabiller,
R. Haque,
O. Sitbon,
X. Jaïs,
...
P. Dartevelle,
S. Maître,
F. Capron,
D. Musset,
G. Simonneau,
M. Humbert
|
8 |
2008 |
8
🐜
|
|
🐜
|
Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.
12 auth.
Aránzazu Campo,
S. Mathai,
J. Le Pavec,
A. Zaiman,
L. Hummers,
Danielle Boyce,
...
Traci Housten,
H. Champion,
N. Lechtzin,
F. Wigley,
R. Girgis,
P. Hassoun
|
7 |
2010 |
7
🐜
|
|
🦁
|
Portopulmonary hypertension: survival and prognostic factors.
11 auth.
J. Le Pavec,
R. Souza,
P. Hervé,
D. Lebrec,
L. Savale,
C. Tcherakian,
...
X. Jaïs,
A. Yaïci,
M. Humbert,
G. Simonneau,
O. Sitbon
|
7 |
2008 |
7
🦁
|
|
🐜
|
HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era
10 auth.
B. Degano,
M. Guillaume,
L. Savale,
D. Montani,
X. Jaïs,
A. Yaici,
...
J. Le Pavec,
M. Humbert,
G. Simonneau,
O. Sitbon
|
7 |
2010 |
7
🐜
|
|
🐜
|
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
18 auth.
D. Montani,
B. Girerd,
X. Jaïs,
M. Lévy,
D. Amar,
L. Savale,
P. Dorfmüller,
A. Seferian,
E. Lau,
M. Eyries,
...
J. Le Pavec,
F. Parent,
D. Bonnet,
F. Soubrier,
E. Fadel,
O. Sitbon,
G. Simonneau,
M. Humbert
|
7 |
2017 |
7
🐜
|
|
🐜
|
Severe hematologic complications after lung transplantation in patients with telomerase complex mutations.
17 auth.
R. Borie,
C. Kannengiesser,
S. Hirschi,
J. Le Pavec,
H. Mal,
E. Bergot,
S. Jouneau,
J. Naccache,
P. Revy,
D. Boutboul,
...
R. Peffault de La Tour,
L. Wémeau-Stervinou,
F. Philit,
J. Cordier,
G. Thabut,
B. Crestani,
V. Cottin
|
6 |
2015 |
6
🐜
|
|
🦁
|
Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.
9 auth.
J. Le Pavec,
G. Lorillon,
X. Jaïs,
C. Tcherakian,
S. Feuillet,
P. Dorfmüller,
...
G. Simonneau,
M. Humbert,
A. Tazi
|
6 |
2012 |
6
🦁
|
|
🦁
|
Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
11 auth.
J. Le Pavec,
R. Girgis,
N. Lechtzin,
S. Mathai,
D. Launay,
L. Hummers,
...
A. Zaiman,
O. Sitbon,
G. Simonneau,
M. Humbert,
P. Hassoun
|
6 |
2011 |
6
🦁
|
|
🐜
|
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
11 auth.
D. Launay,
O. Sitbon,
J. Le Pavec,
L. Savale,
C. Tcherakian,
A. Yaïci,
...
L. Achouh,
F. Parent,
X. Jais,
G. Simonneau,
M. Humbert
|
6 |
2010 |
6
🐜
|
